Methods for drug susceptibility testing of bacteria  by unknown
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amoxicillin, cefazolin, erythromycin, clindamycin, vancomycin, te- 
icoplanin and imipenem. 
Results: Eight different biotypes were identified on the basis of 
three enzyme activities: valine aryl amidase, acid phosphatase, and 
a-galactosidase. Biotype 5 was the most common, followed in de- 
creasing order by biotype 1 and biotype 8. Strains belonging to 
biotype 4 were most sensitive to amoxicillin, cefazolin and ery- 
thromycin, member of biotypes 1 were most sensitive to teicoplanin. 
Conclusions: Our biotyping system, based on a commercial 
method, was simple to perform and provided rapid results, and was 
found to be reproducible. 
I P279 I Standardization and Evaluation of a Enzyme 
lmmunoassay to Detect the Capsular 
Polysacchatide of Streptococcus pneumoniae 
from Serum Samples 
J. Dominguez I ,  N. Sopena ', EJ. Belda ', L. Matas ', 
J.M. Manterola 
P U ~ O ~ ,  Spain, '~iagnostic Gr$& S.A. Barcelona, Spain 
Objectives: Standardization of a ELSA to detect the capsular 
polysaccharide of S. pneumoniae in serum samples. 
Methods: We evaluated 61 patients with pneumococcal pneumo- 
nia. In 31 cases was bacteremic. We also included 102 serum from 
patients with pneumonia without evidence of S. pneumoniae d e c -  
tion. Serum was diluted 1:5 with PBS-Tween and boiled for 5 min 
to dissociation the circulating immuno complexes. The plates were 
coated with 25 yg/ml of omniserum (Statens Seruminstitut, Den- 
mark). The plates were incubated 18 h at 4°C. 100 y1 ofserum were 
incubated 1 h at 37°C. After, 100 y1 of ornniserum conjugated (1 
pg/ml) with biotin was incubated for 30 min at 37°C. Afterwards, 
100 yl of horserahh peroxidase avidin solution was added for 15 
min at 37"C, then 100 yl of substrate (BM blue) was added, and 
the plates were incubated at 22°C for 10 min. The amount of color 
developed was measured at 450 nm. The cut-off value was deter- 
mined as 1.5 times the mean absorbance of 50 serum from blood 
donors. The limit of detection of the ELISA was evaluated using 
pneumococcal vaccine (F'neumovax@23, MSD). 
Results: Pneumococcal antigen was detected in 19 patients with 
bacteremic pneumococcal pneumonia (65.5%), and in 19 with non- 
bacteremic infection (59.3%). Serum from patients with non pneu- 
mococcal pneumonia were negative, except one patient with pneu- 
monia due to Coxiefla burnetti (specificity 99.3%). The h i t  of de- 
tection was 5 ng/ml. 
Conclusions: The standardizated ELISA is a rapid, sensitive and 
specific diagnostic test for pneumococcal pneumonia (bacteremic 
and nonbacteremic). Antigen could be detected in serum from the 
first appearance of symptoms. 
J. Galbe ', V Ausina I .  'Hospital U. Germans Eias i 
/ P280 I Identification of Clinical Bordetella species by 
Cellular Fatty Acid Analysis 
F! Rosseel, A. Van Zeebroeck, J. Philippe, S. Lauwers. Academisch 
Ziekenhuis, Vrije Uniuersiteit Brussel, Brussels, Belgium 
Objectives: To differentiate the clinical species of Bordetefla by cel- 
lular fatty acid analysis and to evaluate the Microbial Identification 
System (MIS-Microbial ID, Inc., Newark, Del.). 
Methods: Cellular fatty acids (CFA) of 57 s t r a i n s  of B. pertussis, 12 
strains of B. parapertussis, 2 strains of B. hofmesii, 3 strains of B. hinzii 
and 10 strains of B. bronchiseptica were examined by gaschromatogra- 
phy with the MIS. CFA fingerprints were related to Sherlock's CLIN 
vers. 3.9 library for bacterial identification. Bacteria were grown on 
charcoal agar supplemented with horse blood and cephalelan; cells 
were harvested and processed according to the standard procedures 
outlined by MIS. 
Results: AU species tested were clearly distinguished by their CFA 
patterns, except B. holmesii and B. hinzii that have very similar pat- 
terns. The CLIN library provided a 100% correct identification to 
species level for B. pertlrssis and B. parapertussis. B. bronchiseptica was 
clearly distinghuished from the other species of Bordetelfa but not 
from other genera (Alcaligenes, Kingella, Yersinia, Senatia a.0.). B. 
hofmesii and B. hinzii were identified by the CLIN library as B. 
avium, a Bordetefla species hitherto not found in humans. B. holmesii 
and B. hinzii are not included in the CLIN vers. 3.9 library, however. 
Conclusions: CFA analysis with MIS is an excellent tool for 
the identification of €3. pertussis and B. parapertussis in the c h c a l  
microbiology laboratory. Addition of two biochemical tests (oxidase 
and urease) allows correct identlfication of B. bronchiseptica, B. hinzii 
and B. hofmesii. 
Methods for drug susceptibility testing of 
bacteria 
Identification of Extended Spectrum 
P-Lactamase (ESBL) Producing 
Enterobacteriaceae by the VITEK-System 
A. Bauernfeind I ,  I. Schneider I ,  R. Jungwirth I ,  K. Kihler '. 'Mar 
uon Pettenkofer-institut, Munchen, FRG, 'BioMk'eux, Niirtingen, FRG 
Objective: How to idenhfy producers of ESBL by automated pro- 
cedures, e.g. the VITEK-system. 
Organisms: Wild-type strains isolated from patients' specimens. 
E. cofi, K .  pneumoniae, S. marcescens, C. jeundii ,  I! mirabifis, S. ty- 
phimurium, S.  paratyphi B producing various ESBL of class A (TEM 
-5, -7, CTX-M-1 and -2, PER-1 and -2) or class C (CMY-1 and 
-2, FOX -2) were included. 
Methods: VITEK susceptibility cards GNS-500 were inoculated 
accordmg to the recommendations of the manufacturer. ESBL ac- 
tivity was evaluated by comparing growth of strains in suspensions 
with c e f t a u b e  or cefotaxime (0.5 mg/l) alone and in combination 
with clavulanate. 
Results. The VITEK-system is highly specific and sensitive for 
detection of strains producing different class A plasmidic ESBL: 
specificity loo%, one S. marcescens producing TEM-6 was not iden- 
died for its ESBL production, probably because this s t r a i n  produces 
an AmpC-type p-lactamase as well. The VITEK-system was unable 
to detect any of the plasmidic class C ESBL. 
Conclusion: We conclude that identification of class A ESBL 
producers by the VITEK-system is highly sensitive and specific, 
while identification of class C ESBL is not possible due to the fact 
that clavulanate does not inhibit b-lactamases of the AmpC-type 
even when the resistance gene is translocated &om the chromo- 
some on to a plasmid. The system should be optimized to detect 
class A enzymes in strains which produce both class A and class C 
B-lactamases. 
-3, -4, -5, -6, -8, -9, -12, -14, -15, -16, -26, SHV -2 to 
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I P282 I Preliminary Results for Susceptibility Testing of 
Enterobacteriaceae to Aminoglycosides Using a 
New System: VlTEK II 
C. Jay 
M. Peyret '. 'bioMhieux, France, 2bioMhieux Vitek, U S A  
The goal was to evaluate the VITEK I1 System for the rapid deter- 
mination of susceptibility of enferics rods to 4 aminoglycosidcs. 
VITEK I1 is a new instrument that allows the automatic rapid 
MIC determination. The growth kinetic is monitored and MIC 
is calculated by an algorithm unique to all clinical s i d c a n t  
Gram-negative rods. The study compared the VITEK I1 to the ref- 
erence MIC (determined by agar ddution according to the NCCLS 
guidelines) for 697 s t r a i n s  belonging to 55 species of Enterobacte- 
riaceae. The level of resistance to each antibiotic was always higher 
than 20%, except for amikacin. The calculated algorithm was defined 
in order to determine MICs within a range of 4 to 7 dilutions which 
includes several internationaly recommended breakpoints (NCCLS, 
CA-SFM, DIN); moreover the range allows to detect low-level re- 
sistance. 
MICs were obtained between 8 h and 10 h for 90% of the strains 
depending ofthe drug. The mean Essential Agreement ( f l  dilution) 
was 97.3% (range: 96.0%98.0%). The Very Major Errors were al- 
ways lower than 0.2%. To resolve the dmrepancies, an agar diffusion 
method and the detection of resistance genes ( d l ,  aa8.22, an@', 
aah'lb) were also performed. 
This preliminary study suggests that the VITEK I1 System is able 
to determine rapidly MIC of major aminoglycosides for Enterobac- 
teriaceae. The testing conditions which are the same for all the other 
Gram-negative rods should make this system easy to use. 
G. Zambardi ' , S. Honnet I ,  L. Meeh ', J.L. Balzer ', 
Comparison of Viiek System with Agar Disk 
Diffusion or Susceptibility Testing of 
Pseudomonas Aeruginosa 
H.C. Berlie', A. Dubois2, E. Guillemet', M.E Gros3. 'Laboratoire 
de Bactbriologie C.H. Alenpn, France, 21. U. 1: Caen, France, 
' bioM&eux, France 
Objectives: This study was conducted in order to compare VITEK 
AMS cards GNS-NY and agar disk &sion (DD) performed ac- 
cording to manufacturer's recommendations and fiench guidelines 
(CA-SFM) using 11 antimicrobial agents (A.A.) for susceptibility 
testing of Pseudomonas amginosa (Fa.). 
Method 186 strains of Pa. were tested, all collected h m  human 
clinical isolates, between September 1995 and may 1996; the serotype 
was determined for each strain. 
Results: The following table shows the percentage of agreement, 
minor (md) and major discrepancies (MD) between the two meth- 
ods, for the whole strains: 
DD 24 h/VITEK (percrnuge) 
A.A Agreement md MD 
Ticardin 89.8 4.3 5.9 
Pipencillin 91.9 7.0 1.1 
CeLulodin 90.9 7.0 2.1 
Armonam 65.2 32.2 2.6 
Ceftazidime 94.1 4.8 1.1 
Inupenern 91.4 7.0 1.6 
Amilum 61.8 36.0 2.2 
Tabnmycin 100.0 0.0 0.0 
clprofoxacin 97.3 0.0 0.2 
Trimethopnrn 90.3 9.7 0.0 
Forfomyhn 83.9 0.0 16.1 
Mic is determined for the strains with MD: 50 MD (14 very 
mjo r  discrepancies (VMD) and 36 MD) were changed in 34 h4D 
(5 VMD and 29 MD) after compared analysis with MIC results. 
Conclusions: VITEK SYSTEM can be used to perform suscep- 
tibility testing of Pseudomonas aeruginosa. 
On 186 strains tested against 11 A.A., only 5 very major discrep- 
ancies appeared. 
lp2841 Evaluation of Viiek Auto-Microbic System" for 
Determination of Antibiotics Susceptibility in 
Coagulase Negative Staphylococci: Comparison 
with Agar Dilution Method 
M.-E. Reverdy, L. Carret, A. Quagha. Dpt ofMicmbiolo~, Hospital 
E Hemot, Lyon, France 
This study is the second part of a Vitek" evaluation for staphylococci 
susceptibility testing in comparison with the reference agar dilution 
method. After studing S. aureus strains,  we have tested here 197 co- 
agulase negative staphylococci strains including 29 Merent species. 
12 antibiotics and p-lactamase production were studied. Concern- 
ing oxacillin, NaCl supplementation was 4% for MICs determination 
and 2% in Vitek" GPS-IP cards. 
Vitek System" was providing the following results after 11 hours 
of incubation: 
Antibiotics Agreement Very Minor+ Sensitivity Spccifiuty 
% mjor major errors 96 
errors % 
% 
Oncdlin 
Gcntarmun 
Temcyclme 
Erythmmymn 
Prlrunamycm 
Fosfomyan 
OBOncln 
hf impm 
F w d c  acid 
Vancomymn 
Colrlmaxvole 
94.9 1/71 4.6 
94.9 1/56 4.6 
97 1/35 2.5 
1/77 4.6 94.9 
95.4 0/4 4.6 
84.3 5/78 13.2 
85.8 3/60 12.7 
98 0/30 3 
80.2 011 19.8 
100 0 0 
95.9 1/3 - 
98.6 
98.2 
97.1 
93.5 
414 
93.6 
81.7 
100 
111 
- 
- 
92.8 
97.8 
97.5 
98.3 
95.3 
78.2 
98.4 
97.6 
95.6 
98.0 
100 
Except for 3 antibiotics (fosfomycin. ofloxacin. fucidic acid) the 
accuracy of Vitek" is acceptable (agreement 294.9% and very major 
errors t3%). Discrepancies are mainly due to Merences between 
CA-SFM breakpoints and Vitek@ breakpoints as well as to one ddu- 
tion step Merence with MICs. 
Rapid Susceptibility Testing of 
Enterobacteriaceae: Comparison of the Results 
of the VITEK and the Merlin System 
K.A. Hengstler', A. P o s t u l k a 2 ,  H. Backes3, A.-M. Fahr'. 
'Laboratory Group, Depf. ofMinobiology, Heidelberg, Germany, 
'BioMhrieux, Niirtingen, Germany, 'Merlin, Bornheim, Germany 
Objectives: The Vitek system (bioMkrieux, Hazelwood, MO, 
USA) was compared to the Merlin System (Merlin, Bornheim, Ger- 
many) for the rapid susceptibhty pattern of members of the family 
Enterobacteriaceae. 
Methods In this study the mean time-to-result and the rapid 
susceptibility test patterns (sensitive (S), intermediate (I), and re- 
sistent @) according to DIN 5894014) of the Vitek and the Mer- 
lin System for 90 strains of the f d y  Enterobacteriaceae were 
compared. The isolates included the following species: Eschprichia 
coli, Klebsiella sp, Roteus sp, Enterobacter sp., Citrobacter sp, Sewa- 
tin sp., and MorganeZla morganii. 10 antimicrobial agents were cho- 
sen: Ampicillin, Ampicillin/Sulbactam, Piperacillin, Imipenem, Ce- 
fazolin, Cefotaxim, Gentamicin, Amikacin, Ofloxacin, and Cotri- 
Methods for drug susceptibility testing of bacteria 61 
moxazol (Vitek GNS-500 card Merlin panel El-707-001). Dis- 
crepant results were compared to 24 hours microdilution MIC and 
E-Test. 
Results: The mean time-to-result for the Vitek cards was 
6 hours, 5 hours for the Merlin panels. With 900 single test 
pairs performed we found 29 (3.2%) s id icant  discrepancies be- 
tween both systems concerning the following antibiotics: Ampi- 
cillln, AmpicihdSulbactam, Piperacdhn, Imipenem, Cefazolin, Ce- 
f o h ,  Ofloxacin, and Cotrimoxazol. 
Conclusions: Rapid susceptibility testing and same-day-report- 
ing of results is a valuable alternative to over-night antimicrobial 
tests. 
I P286 I Reproducibility of MlCs Determined by a New 
M. Ghanem I ,  C. Meunier ’, V Chaudet ’, C. Bradford I ,  
S. Fitzsimtnons’, G. Zambardi’. ‘bioMbrieux Vitek, USA, 
System: VITEK II 
bioMirieux, France 
One of the main advantages expected for an automated instrument 
for antimicrobial susceptibility testing is the standardization of the 
method and therefore the good reproducibility of the results. The 
goal of this study is to analyse the reproducibility of the VITEK I1 
System. 
VITEK I1 is a new instrument that allows the automatic rapid 
MIC determination by monitoring growth kmetics independencely 
of bacterial idennfication. The calculated algorithm was defined in 
order to determine MICs within a range of 4 to 7 dilutions which 
includes several internationally recommended breakpoints (NCCLS, 
CA-SFM, DIN); moreover the range allows to detect low-level re- 
sistance. The study was performed on 56 strains of Enterobacteriaceae 
and non-fermenting Gram-negative bacilli exhibiting dif€erent levels 
of resistance. 11 common drugs (7 p-lactams and 4 aminoglycosides) 
were tested. For each strain, 9 MIC values were determined (3 times, 
3 days) using 3 merent lots of reagents and 3 VITEK I1 instruments; 
4 MIC values were also determined using the agar dution reference 
method. 
The mean times to obtain MICs were h m  5 h to 8 h. Compared 
to the more frequent data, the complete agreement (same MIC) 
varied fium 83.0% to 97.0% for VITEK I1 and fium 68.0% to 91.7% 
for the reference method. The Essenaal Agreement (* 1 dilution) 
was always higher than 97.0% for both VITEK I1 and reference 
method. 
ms study demonstrates the hgh reproducibllity of VITEK I1 
compared to the reference method for common p-lactams and 
aminoglycosides. No lot, prototype, day effects have been observed. 
of resistance to each antibiotic was always higher than 20%. except 
for amikacin (12.4%). The calculated algorithm was defined 111 or- 
der to determine MICs within a range of 4 to 7 dilutions which 
includes several internationally recommended breakpoints (NCCLS, 
CA-SFM, DIN); moreover the range allows to detect low-level re- 
sistance. 
MICs were obtained between 9 h and 14.5 h for 90% of the 
strains depending of the drug. The mean Essential Agreement (.t 1 
dution) was 96.4% (range: 89.9%99.2%). The Very Major Errors 
were always lower than 0.8%. The resistance profiles were analyzed 
in order to resolve the cbscrepancies. 
This preliminary study suggests that the VITEK I1 System is able 
to determine rapidly MIC of major antibiotics for P aeruginosa. The 
testing conditions which are the same for all the other Gram-negative 
rods should make this system easy to use. 
Preliminary Results for Susceptibility Testing of 
Entembacteriaceae to Various P-Lactams Using 
a New System: VITEK II 
M. Peyret I ,  D. Leahart I ,  V Blanc ’, L. Nougier ’, M. Ullery I ,  
J. Gerst I .  biokfkieux Vitek, USA, ’bioMkieux, France 
The goal was to evaluate the VITEK I1 System for the rapid deter- 
mination of susceptibility of enteric rods to 15 p-lactams. 
VITEK I1 is a new instrument that allows the automatic rapid 
MIC determination. The growth kmetic is monitored and MIC 
is calculated by an algorithm unique to all clinical sigruficant 
Gram-negative rods. The study compared the VITEK I1 to the ref- 
erence MIC (determined by agar dilution according to the NCCLS 
guidelines) for 697 independent strains of Enterobacteriaceae belong- 
ing to 55 species. The level of resistance to each antibiotic was 
always higher than 30%, except for third-generation cephalosporins 
(10%-20%) and imipenem. The calculated algorithm was defined in 
order to determine MICs withm a range of 4 to 7 dilutions which 
includes several internationally recommended breakpoints (NCCLS, 
CA-SFM, DIN); moreover the range allows to detect low-level re- 
sistance. 
MICs were obtained between 5 h and 8 h for 90% of the strains 
depending of the drug. The mean Essential Agreement (& 1 dilu- 
tion) was 93.5% (range: 88.4?&97.2%). The Very Major Errors were 
always lower than 1.5%, except for cefoxitin (3.5%) and cefcazidime 
(3.0%). The resistance profiles were analyzed in order to resolve the 
discrepancies. 
This preliminary study suggests that the VITEK I1 System is able 
to determine rapidly MIC of p-lactams for Enterobacteriaceae. The 
testing conditions which are the same for all the other Gram-negative 
rods should make this system easy to use. 
LP287 I Preliminary Results for Susceptibility Testing of 
Pseudomonas aeruginosa Using a New System: 
VITEK II 
C. Jay 
M. Peyret ’. ‘bioMkieux, France, ’bioMkrieux Vitek, USA 
The goal was to evaluate the VITEK I1 System for the rapid deter- 
mination of susceptibhty of Pseudowonas aemginosa to representative 
antibiotics including 6 p - l a w ,  4 aminoglycosides and 1 fluoro- 
quinolone. 
VITEK I1 is a new instrument that allows the automatic rapid 
MIC determination. The growth kinetic is monitored and MIC 
is calculated by an algorithm unique to all clinical significant 
Gram-negative rods. The study compared the VITEK I1 to the ref- 
erence MIC (determined by agar dilution according to the NCCLS 
guidelines) for 122 independent strains of P aeruginosa. The level 
C. Shubert *, D. Parreno I ,  S. Petre M.T. Albertini 
Susceptibility Testing of Anaerobic Bacteria: 
Evaluation of the Redesigned ATB ANA (Version 
96) bioMerieux 
L. Dubreuil, I. Houcke. Facufd de Phrmacie, Lille, France 
Objectives: We compared the susceptibility results of 200 clinical 
anaerobes against 9 antibiotics using a new ATB ANA (bioMirieux) 
device with those of the NCCLS standard agar dilution method. 
Methods: The new ATB ANA device allowed the clinical 
categorization of the investigated strains according to the fiench 
(CA-SFM) or american (NCCLS) breakpoints. For a better eval- 
uation of the device we added some resistant B. jagilis p u p  strains 
h m  our own collection: 3, 6 and 12 s t r a i n s  respectively resistant 
to imipenem, ticarcillin + clavulanic acid and co-amoxclav and 2 
other strains with decreased susceptibility to memnidazole (MIC = 
62 Journal of Clinical Microbiology and Infection, Volume 3 Supplement 2 
8 mg/l). For some strains that did not grow on ATB S medium, tests 
were performed using the West Wilkins medium supplemented with 
agar 1.5%. 
Results: According to the CA-SFM or NCCLS breakpoints, 
we observed the following percentages: categorical agreement 
(93.4-94.9%), minor discrepancies (5.5-3.8%), major dtscrepancies 
(0.647%) and very major discrepancies (0.5-0.6%), respectively. 
ATB ANA was able to detect the low-level meaonidazole resis- 
tant B.  jagilis strains using the k n c h  breakpoints but not with the 
NCCLS ones. For B.jagilis and B lactamase + Preuofella strains, the 
clustering effect of the amoxicillin MICs around the fkench break- 
points led to more hquent minor discrepancies. 
Conclusions: ATB ANA is a very convenient method to deter- 
mine the antibiotic susceptibility of anaerobes. Results obtained by 
ATB ANA correlated well with those of the reference method. 
(TCC 32/2 and 64/2), cefoxitin (CXT 16/32), cefotetan (CTT 
16/32), imipenem (IMI 4/8), dindamycin (CLI 2/4), chloram- 
phenicol (CMP 8/16) and metronidazole (MTR 8/16). The system 
allows categorization of organisms into the susceptible, intermediate 
or resistant category. 
Results: The table shows the number of strains falsely categorized 
by ATB ANA as compared to the NCCLS agar reference procedure. 
Ten (0.86%) very major (susceptible instead of resistant), 1 (0.09%) 
major (resistant instead of susceptible), and 52 (4.5%) minor discrep- 
ancies were observed. 
Discrepancia PEN AMC PIC TZP TCC CXT CTT IMI CLI CMP 
MTR 
Minor 6 2  9 3 1  1 0 4 1 1 0 6  
Major 1 
very m,or 1 2  1 1 5  
IP290] Susceptibility Testing of Anaerobes with the 
A. S e a a n  ' , S. Bland J.L. Tissier '. 'laboratoire de Bocfiriologie 
C H  Annecy, France, 'bio Mkieux Mary Z'tfoile, France 
The ATB ANA is a commercially available microtray in conjunction 
with semi automated intrument (bio (Mtrieux). 
The new ATB ANA is composed of ten antibiotics with two 
break points accordmg to the NCCLS recommendations, three an- 
tibiotics with three concentrations: Amoxlcillin (2-4 and 16 mg/l), 
Meaonidazole (4, 8 and 16 mg/l) and Amoxi& + clavulanic acid 
(4/2, 8/4, 16/2 mg/l) and Ticardm with one concentration (64 
mg/l) . 
We have tested 157 clinically important anaerobes isolated in our 
laboratory: Bucferoides jagilis group (50 strains) Preuofella species (36) 
Fusobucfm'um species (15) Clostridium (25) Peptostreptococcus and Gram 
posifiue r ods (25).  We have also used five reference strains Bucferoidec 
jugilis, B. thetuoiominon, Pepfostrepfocornrs magnw, C. perf.ngens and E.  
kntum. 
The strips were incubated anaerobiocally for 48 hours. The tur- 
bidity of each well was read with the ATB 1510 and the result 
interpreted by the ATB microprocessor. We have also compared the 
results with reference agar dilution for six antibiotics. 
The concordance between the two methods was 90% for Boc- 
fzroidesjagilis group, 95% to 97% for other anaerobes. 8% minor 
discrepancies were found for Fraghs group and only 2% major dis- 
crepancies. But we did not obtained growth for some gram positive 
bacteria. 
The new ATB ANA is a good reliable and useful technic for 
anaerobes antibiotics testing. 
New ATB ANA 
[El ATB ANA System for Susceptibility Testing of 
R. Zbinden ' , J. Wiist ', E. Kiimin EH. Kayser ' . 'Department of 
Medial Microbiolon, Uniumity of Zurich, Zurich, Switzerland, 'Labor 
Media, Zurich, Switzerland 
Objective: To evaluate the performance of the ATB ANA System. 
Methods: Susceptibilities of 106 anaerobes (12 Prevotella spp., 
50 Bacteroides spp., 9 Fusobucten'um spp.. 10 Peptosfreptococcus spp., 5 
Propionibaaerium ~ z e s  and 20 Clostridium spp.) isolated h m  din- 
ical specimens collected in 1996 were tested by the new ATB 
ANA system (breakpoint procedure, BioMhrieux) and the NCCLS 
reference agar dilution method. The ATB ANA System includes 
two concentrations (mg/l) each of penicillin (PEN 0.5/2), amox- 
icillin/davulanate (AMC 4/2 and 8/4), piperacillin (PIC 32/64), 
piperacillin/ta.zobactam (TZP 32/4 and 64/4), ticarcillin/clavulanate 
Anaerobes 
Conclusion: ATB ANA offers a good alternative to the NCCLS 
agar dilution method for susceptibilty testing of anaerobes. 
Comparison of Methods for Assessing Synergic 
Antibiotic Interactions 
I.M. Gould, M.L. Mackay, K. m e .  Dept. ofMicrobiology Royal 
Infrnnary Aberdeen, Scotland 
25 combined microtitre checkerboard/time kill curves were per- 
formed on 10 isolates i h m  patients with refiactory infection to as- 
sess antibiotic combinations of bacteriadal agents. The isolates were 
B. cepucia (7), S. a u m  (2) and K. pneumoniue (1). No antagonism 
(FICI or FBCI >4) was observed with any combination. Synergy 
by kill curve (present in 21) was much more often seen at 24 h 
than 2 or 5 h (P < 0.001). On comparing the mean of the FICI 
and FBCI values there were sigruficant merences in only four (p < 
0.05). The same checkerboard was repeated on 3 separate days to test 
reproducibihty. There were no sigdcant dif€erences (p =- 0.05). AU 
boards synergic (50.5) by FBCI (8) were synergic by FICI. Synergy 
by FICI (12) predicted synergy by FBCI in 67%. AU boards synergic 
by FICI were synergic by time kill at 24 h but there was a poor cor- 
relation between synergy at 2 or 5 h and synergy by FICI or FBCI. 
In conclusion combining time kill and checkerboard tests gives re- 
producible results and good correlation between FICI's and FBCIs. 
FICI's showing synergy were also pred~ctive of synergy in time kill 
studies. For bactericidal combinations u&ly to be antagonistic cal- 
culation of FICI's is a good indicator of synergic bactericidal activity. 
151 Comparison of Four Methods to Evaluate the 
Susceptibility of Acinetobacter baumannii to 
lmipenem (IMP) 
A. Pascual, L. Martinez-Martinez, M.J. Clavijo, M.D. Garcia-Perea, 
E.J. Perea. Dpf of Microbiology University Hospital K Mumrenu, School 
of Medicine, Seville, Spain 
Objectives: A. baumunnii is a nosocomial pathogen of increas- 
ing importance. Multiresistant strains are being isolated worldwide. 
Some commercdy available susceptibility testing systems (i.e. Pasco, 
Difco, USA) do not include W. T h  may make it necessary to test 
the agent against strains resistant to commonly used antimicrobial 
agents. 
Methods: Four methods have been evaluated to determine 
the activity of IMP against 50 clinical isolates of A. buumannii: 
disk-as ion  @D), agar dilution (AD), microdilution (MD) and 
E-test. The three former methods were performed accordmg to the 
NCCLS guidelines. E-test was assayed on Mueller-Hinton agar ac- 
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cording to the manufacturers. For E-test, the results were rounded 
up to the next higher twofold dilution. 
Results: Results were interpreted accorckng to the NCCLS 
breakpoints. Agreement between the different methods was: AD 
vs. MD 86%, E-test vs. MD 90%. and E-test vs. AD 94%. When 
interpretative categories were compared, one very major error (AD 
vs. MD) and three major errors (one for each MD, AD, and E-test 
vs. DD) were observed. Minor errors detected were: 
Errors AD/MD E-tert/MD E-test/AD MD/DD AD/DD E-tert/DD 
Minor 8 5 11 7 11 11 
Conclusions: In spite of the number of minor errors detected 
overall there was good agreement among the four methods evalu- 
ated. In our opinion the E-test is a simple and reliable quantitative 
assay to determine the activity of IMP against A .  baumannii. 
Implementation of a Selective Medium to the 
Screening for Ticarcillin Resistant fseudomonas 
aemginosa Carriers 
M. Eveillard 
A. Mangeol', E Fauvelle '. 'Department $Hygiene, 'Department .f 
Microbiolofl, C H I  Mon$meil, France 
Objective: If the risk of multi-resistant I! aeruginosa mss-transmis- 
sion is lower than for meticillin resistant Staphylococnrs aureus, it is 
probably not insigmFicant. Thus, we tried to implement a selective 
medium to the screening of ticarcillin resistant I! amginosa carriers. 
Methods: We added different concentrations of ticarcillin to an 
agar medium containing cetrimide (selective for I! aeruginosa and sev- 
eral enterobacteriaceae) and we tested the culture of 32 I! aeruginosa 
strains (from hospital environment and clinical samples) who had 
various susceptibihties to ticarcillin. These susceptibilities were de- 
termined by a disk *sion test. Standard bacterial inoculum tested 
were about 5.10' bacteria/ml. 
Results: We idenafied a concentration (40 mg/l) that dowed 
a selective isolation of ticarcillin resistant I! aeruginosa. An inocu- 
lum effect was only observed for intermediate susceptibility strains 
at very lugh concentrations (5.108 bacteria/ml). The ddferenciation 
between I? aemginosa and cetrimide resistant enterobacteriaceae (es- 
pecially Senatia marcescens and Enterobacter sp.) has been performed 
easily (oxydase test and pigmentation of I? amginosa strains). The 
culture with ticarcillin did not change I! nmginosa susceptibility 
to antibiotics (beta-lactamines, aminoglycosides, fluoroquinolones). 
Thus, these susceptibilities can be checked after an isolation on such 
a medium. Finally this medium could keep his selectivity after three 
weeks of conservation at 4°C. 
Conclusion: This selective medium seems to be efficiency for the 
isolation of our hospital resistant I! amginosa strains. Nevertheless, 
according to us, ticarcillin concentration included in cetrimide agar 
has to be related to local microbial ecology in each hospital. More- 
over, if the rate of this antibiotic resistant s& is above 40%, the 
use of a more selective antibiotic like ceftawdime is probably better. 
K. Lecointre I ,  L. Guet ', C. Goudin I ,  
I P295 I Determination of Extended Spectrum 
Betalactamases by Double-Disk Synergy 
Method and E Test 
Y. Nas, H. Leblebicio&, C. Erogu, M. Siinbiil, M. Giinaydin. 
Ondokuz Mayis University, Medical School, Samsun, Tiirkiye 
Objective: To determine the prevalence of extended spectrum be- 
talactamases (ESBLs) by double-duk synergy method and E Test in 
Escherichia coli and Klebsiello pneumoniae. 
Methods: 129 E. coli and 128 K .  pneumoniae were consecutlvely 
collected from various body sites of intensive care patients. The 
presence of betalactamases was investigated by the nitrocefin dlsk 
method. ESBL production was determined by both double-disk 
synergy method and E Test. Standart &sk a u s i o n  test was per- 
formed to determine the susceptibilities of cefodzime, ceftizoxime, 
cefcazidime, cefhiaxone, cefotaxime, cefoperazone and aztreonam. 
Results: Betalactamases were detected in 66 (51.2%) of E. coli 
and 107 (83.6%) of K .  pneumoniae. ESBL production was observed 
in 19 (14.7%) of 129 E. coli and 67 (52.3%) of 128 K. pneumoniae 
by double-disk synergy method, and in 15.5% of E. coli and 55.5% 
of K .  pneumoniae by E Test. Among the ESBLs positive s t r a i n s  11 of 
them were susceptible to ceftizoxime, 6 to ceftandime 2 susceptible 
to ceftriaxone, cefotaxime and aztreonam, and one to cefoperazone 
by disk ddfusion test. All ESBLs positive strains were resistant to 
cefodizime. 
Conclusion: Both methods are practicable for the detection of 
ESBLs in clinical laboratory. False susceptibihty to cephalosporins 
might be found among ESBL positive strains by disk diesion 
test and therefore laboratories should perform double-disk synergy 
method or E Test to rule out false-susceptible results. 
The Determination of Bacterial Sensitivity to 
Azithromycin by the Disc Diffusion Method and 
"E" Test 
E. D6sa, I. Szoke, K. Birsony, E. Nagy. Department of Clinical 
Microbiolofl, Albert Szent-GyBrgyi Medical University of Szeged, 
Hungary 
Objectives: At the determination of the in vitro sensitivity of bac- 
teria to azithromycin it is not sufficient to test the sensitivity of the 
bacteria to erythromycin, the "class" antibiotic of macrolides. 
Methods: In cases of diseases, caused by pathogens for the treat- 
ment of which azithromycin can be considered (Streptococcus pyogenes, 
Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus infuenzae, 
Moruxella catarrhalis), sensitivity to it has to be separately tested by the 
in vim disc a s i o n  method, taking into consideration the NCCLS 
prescriptions, concerning inhibition zone diameter and sensitivity 
break points. The results were confirmed in 350 cases of 1741 by 
MIC values determined by the "E" test. 
Results: 91.4% of S. aureus, 83.4% of S. pneumoniae, 100% of S. 
pyogenes, 92.8% of H .  infuenzae, 94% of M. catarrhalis were sensitive 
to azithromycin. The results were remarkable in cases of H .  infuenzae 
and M .  catarrhalis. 
Conclusions: It is justified to investigate separately bacterial sen- 
sitivity to azithromycin and erythromycin by the in vitro disk &- 
sion method. 
m] Comparison of 4 Methods for Testing 4 
P-Lactams and 3 Aminoglycosides against 
fseudomonas aemginosa (n = 100) 
V. Vernet-Garnier L. Brasme I ,  J. Madow M. Prulhiere I ,  
J.D. C a d 0  '. 'CHRU,  Reims, France, ' H I A  Bgin,  St Mande, France 
We compare results of 4 susceptibility testing methods to 4 B-lactams 
(ticarcfin [TIC], ticarcillin + davulanic acid [TCC], ceftazidime 
[CAZ] and cefepime [CFP]) and 3 aminoglycosides (gentamicin 
[GEN], tobramycin [TOB] and amikacin [AKNI): disk *sion, 
API systems: ATB PSE (bioMkrieux, France), experimental ATB 
PSE-3 (MIC microdilution broth test) and MIC agar dilution as 
reference method. We selected 100 isolates of Pseudomom aemgi- 
nosa: 27 producing cephalosporinase, 53 penicillinase (18 PSE 1-4, 
20 OXA 1 4 ,  5 OXA 6, 10 TEM 1-2), 10 clinical isolates with 
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unknown phenotype. Results were classified according to CA-SFM 
criteria. 
The following table shows dlscrepancies between c h c a l  cate- 
gories obtained with reference method and the 3 other methods and 
agreement within f l  dilution for experimental ATB PSE-3 MICs: 
Antibiotics % dscrcprncicr MIC fl dil. 
("h agreement) 
Dirk ATB PSE ATB PSE-3 
77"" 
TIC 20 32 16 100 
TCC 46 48 6 100 
CAZ 20 12 18 98 
CFP 14 14 100 
GEN 20 24 22 94 
TOB 4 4 2 94 
AKN 16 18 14 90 
- 
Our results show no Werence between c h c a l  categories with 
ATB PSE and disk &sion methods, moreover experimental ATB 
PSE-3 strip is a practical and rehable method for determining MICs 
of I! aarginosa to tested antibiotics 
Performance of Biomic for Reading Zone 
Diameters of Agar Disk Diffusion Plates 
J.A. Kemme, J.H. Sloos, C.P.A. van Boven, L. Dijkshoorn. Leiden 
Universify Hospital, Leiden, The Netherlands 
Automated systems for susceptibihty testing of clinical isolates are 
mainly based on the determimation of MICs. We investigated the 
performance of Biomic (Giles Scientific, Inc., Ny, USA), a semiau- 
tomatic system for reading of zone diameters of disk difhsion plates. 
Agar disk &ion plates of 108 clinical isolates (98 patients) were 
tested using two drug panels, encompassing a total of 16 different 
antibiotics. Zone measurements were performed in duplicate, both 
with Biomic and manually by one individual to test the reproducibil- 
ity. Both types of readings were reproducible. Apart fiom t h i s ,  the 
accuracy was tested. For this purpose, Biomic readings were com- 
pared with readings obtained fiom several technicians of our labora- 
tory ("gold standard"). A total of 874 drug-organism combinations 
were tested. Of these, 251 (28.7%) showed zone diameter differences 
t l  mm and 814 (93.1%) displayed differences <5 mm. Conversion 
of in total 736/874 drug-organism combinations into susceptibhty 
categories (S, I, R) demonstrated 1/93 (1.1%) very major error (te- 
icoplanin), 3/553 (0.5%) major errors (teicoplanin, cefamandole) and 
43/736 (5.8%) minor errors between Biomic and laboratory read- 
ings. Major and very major errors were reported for Gram-positive 
species, only. In our hands, Biomic proved to be reproducible and 
accurate for zone dmneter measurements. 
I P299 I The Advanced Expert System. 1) A New 
Approach to Antimicrobial Susceptibility Testing 
Interpretation 
J.M. B o e u w ,  A. Lazzarini, M. Peyret, J. Zindel. bioMhieux, 
France 
Expert systems became a common tool to help interpreting suscepti- 
bility test results. Most of them rely on rule-based inference engines, 
and on knowledge bases very specific. A new expert system relying 
on a dedicated inference engine and on an extensive knowledge base 
is described here. 
The interpretation of a susceptibility test result includes three 
steps. The fmt step - biological dda t ion  - aims to validate re- 
sults consistency and to do phenotypic resistance mechanism recog- 
nition; it consists in comparing the observed MICs of the antibiotics 
tested for a given strain, to reference results stored in the knowledge 
base. The second step - therapeutic interpretation - aims to predict 
the therapeutic efficiency. It combines the category interpretation 
based the recommended breakpoints with the recognized resistance 
mechanism to deduce the most likely interpretation for each tested 
antibiotic. In addition, it allows the deduction of the expected sus- 
ceptibility category for not tested antibiotics. The third step consists 
in commenting the results to inform about some risks linked to 
specific resistance mechanisms. 
The knowledge base has been built using relevant published 
data; the resistance mechanisms are described as MIC distributions. 
This information is independent fiom category interpretations. The 
knowledge used for the nvo other steps depends on national com- 
mittees recommendations and local situations, and can be modified 
by the biologists. 
This system, when linked to a susceptibility testing automate, 
makes worldwide accepted expert knowledge available for routine 
testing. 
I P300 I The Advanced Expert System. 2) Performance 
for Phenotypic Resistance Mechanism 
Recognition 
J.M. Boeu@ras, R .  Vachon, J.L. Balzer, C. Davenas, A. Rongier, 
M. Tarpin, M. Peyret. bioMhiew, France 
The Advanced Expert System is a new system performing validation 
and interpretive readmg of susceptibhty test results, owing to phe- 
notypic resistance mechanism recognition. The present study aimed 
to adjust its operating parameters, and to estimate the quality ofphe- 
notypic recognition. 1264 resistance patterns have been obtained on 
Enterobacferiaceae strains fiom various origins, representative of resis- 
tance mechanisms to Betalactams, Aminoglycosides and Quinolones. 
Each pattern is defined by the MICs of antibiotics belonging to the 
same family for a given strain.  Resistance mechanisms have been 
determined by human experts. 579 of these patterns have been used 
as a learning set to adjust the operating parameters; 685 were used as 
a test set to assess the performance. 
On the test set, the global agreement with the human experts was 
98.1%. and the discrimination w 55.0%. The error rate was 1.6%. 
The results did not d&er fiom those obtained on the learning set. 
Most of the cases of poor bcrimination were linked to 3 specific 
pairs of resistance mechanisms, because of the antibiotic selection in 
the considered pattern, or of the concentrations tested. A resolution 
of these 3 problems would lead to a 89.9% discrimination. 
The Advanced expert system showed promising results for phe- 
notypic resistance mechanisms recognition. Although bcrimination 
might be insufficient in theory with some antibiotics and concen- 
trations selected for routine, t h i s  study demonstrates that chcally 
relevant resistance mechanisms could be recogmxd. 
F] Newly Improved Aareonam and Piperacillin 
Formulations in Sceptor Panels 
W. Brasso, D. Holliday, P. Hammond, T. Karr, J. Hejna. -on 
Dickinson Minobiology Systems, Spark, Marylnnd, USA 
Objectives: To improve the performance of Aztreonam (ATM) and 
Piperacillin (PIP) formulations in Sceptor panels. 
Methods: Two antimimbics, ATM and PIP, were disclaimed in 
Sceptor MIC and MIC/ID panels following the detection of false 
susceptible results, i.e. Very Major Errors (VME) during routine 
quality control audits. Initial internal studies confirmed a VME rate 
of %20% and 5% for ATM and PIP, respectively. Recent reformu- 
lations have been completed for each of these antimimbics and an 
evaluation was conducted comparing the new preparations to the 
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NCCLS reference microdilution method, and to the old formulas. 
A total of 401 gram-positive and gram-negative isolates were tested 
with PIP (148 PIP-resistant) and 246 gram-negative strains with 
ATM (114 ATM-resistant). 
Results: Essential Accord (EA), i.e. percentage within & one 
dilution, for the new ATM was 95.5% with 1.7% VME compared 
with 77.0% EA and 13.3% VME with the previous formula. Two 
strains of Burkholderia repacia accounted for both VME. For PIP, the 
EA was 97.0% with 0% VME using the new formula, and 93.7% EA 
and 2.7% VME with the old formula. Reproducibility was 98% and 
97% respectively for the new ATM and PIP 
Conclusions: The new Sceptor formulations for ATM and PIP 
showed a sigtllficant improvement in EA and the rate of VME over 
the previous formulas and will soon be reintroduced into Sceptor 
panels. 
I P302 I Evaluation of an Improved Formulation of 
Ceftriaxone (CRO) in Sceptor MIC Panels 
W. Brasso, D. Hohday, F! Hammond, J. Hejna. Becton Dickinson 
Microbiology Systems, Sparks, Maryland, USA 
Objective: To improve the performance of Ceftriaxone in Sceptor 
MIC and MICAD panels. 
Methods: Current Sceptor panels &claim use of CRO be- 
cause of d&culties in detection of resistance by Gram-Negative 
organisms (Enterobacter and Citrobacter primarily) that constitu- 
itively hyper-produce beta-lactamase. Th~s  tudy evaluated an im- 
proved formulation of CRO in a comparison to the NCCLS ref- 
erence microdilution method. A total of 252 strains, including 195 
Gram-negative organisms (76 resistant to CRO), were included in 
this study. 
Results: The new formulation was found to have a level of Es- 
sential Accord (EA), or % withm plus or minus 1 doubling ddution 
of the reference MIC, of 93.7% compared to a level of 78.2% with 
the old formula. The number of Very Major Errors (VME) also 
improved considerably with the new formula h m  10 (13.2%) to 
2 (2.6%). Both VME seen with the new formula occurred with 
Burkholderia cepm'a isolates. Although the 6 other isolates of this or- 
ganism tested in the study did not result in VME, the level of MIC 
comparability was poor, with a total EA of 25% for all 8 isolates. 
Since CRO is not indicated for treament of infection caused by 
this organism, a disclaimer for CRO and B.  cepan'a should not pose 
any &fficulty. With B. cepm'a excluded h m  the data, there were no 
VME, and the level of EA improved to 95.9%. 
Conclusions: The new formulation for CRO in Sceptor panels 
was found to give hghly comparable results to the NCCLS microdi- 
lution method for all isolates except B. cepuciu. 
Mechanisms of antibiotic resistance in 
Gram-positive bacteria 
Increased Adhesion of Fluoroquinolone- 
Resistant Staphylococcus aureus Exposed to 
Subinhibtory Levels of Ciprofloxacin 
C. Bisognano', F! Vaudaux', D.P Lew', E.Y.W. Ng2, 
D.C. Hooper2. 'Division o f l ~ j k t i o u s  &eases, University Hospital, 
CH- 12 11 Geneva 14, Geneva, Switzerland, zlnJectious Disease Unit, 
MCH, H a m r d  Medical School, Boston, U S A  
Objectives: This study evaluated the effect of fluoroquinolone 
(flq) resistance determinants on S. aurew adhesion to solid-phase 
fibronectin, whch is specifically mediated by two surface-located 
fibronectin-binding proteins. 
Methods: Isogenic mutants expressing various levels of quinolone 
resistance, were tested in an in vitro bacterial adhesion assay using 
PMMA coverslips coated with increasing amounts of fibronectin. 
These strains contained single or combined mutations in the three 
major loci contributing to flq resistance, namely grL4, g y d ,  andJqB, 
coding for altered topoisomerase N, DNA gyrase, and increased 
norA-mediated efflux of flq, respectively. 
Results: Adhesion characteristics of the diEerent quinolone-re- 
sistant mutants grown in the absence of flq showed only minor dd- 
ferences from those of parental strains. However, more important 
changes in adhesion were exhibited by mutants highly resistant to 
quinolones following their exponential growth in the presence of 
MIC of ciprofloxacin. Increased bacterial adhesion of the highly 
quinolone-resistant mutants, which contained combined mutations 
in grL4 and gyrA, was associated with and e x p h e d  by the over- 
expression of their fibronectin-binding proteins assessed by Western 
ligand affmity blotting. 
Conclusions: These findings contradict the notion that subin- 
hibitory concentrations of antibiotics generally decrease the viru- 
lence of S. aureus. Perhaps the increased adhesion of s. nureus strains 
highly resistant to flq may conmbute in part to that emergence in 
c h c a l  settings. 
I P304 1 Transfer of Mupirocin Resistance and 
Mobilisation of Non-Conjugative Plasmids in S. 
aureus 
E.E. Udo, L.E. Jacob. Faculty ofMedicine, Kuwait University, Kuwait 
Objectives: To isolate and characterise a mupirocin resistance plas- 
mid b m  a mupirocin- and rnethicillin-resistant S. aureus isolate, 
MB494. 
Results: MB494 harboured two plasmids of 40 and 3.0 kilobases. 
In conjugation experiments, it transferred high-level mupirocin and 
erythromycin resistance to laboratory recipient strains.  Plasmid anal- 
ysis revealed that the mupirocin-resistant transconjugants contained 
a 32 kb or 32 and 3.0 kb plasmids. Further transfer experiments 
confirmed that the 32 kb plasmid (pXU12) was a conjugative plas- 
mid, encoded mupirocin resistance and had mobilized the 3.0 kb 
erythromycin resistance plasmid. Experiments conducted to study if 
pXU12 could mobilise other non-conjugative plasmids showed that 
it mobilised nine of 10 non-conjugative plasmids tested. EcoRI re- 
striction digest ofpXU12 demonstrated that it was the 40 kb plasmid 
in MB494 that had lost an 8 kb EcoRI Merit during conjugation. 
Conclusion: Despite the absence of cross resistance between 
mupirocin and other antibiotics, the ability of mupirocin resistance 
plasmids, such as pXU12, to mobhse non conjugative plasmids can 
enhance the spread of other resistance determinants among hospital 
staphylococci. 
1 P305 [ Spontaneous Deletion of 30 kb Chromosomal 
DNA Correlates with a Reduction in Wall 
Teichoic Acid in Staphylococcus aureus 
R. Jenni, B. Berger-Bachi. Institute of Medical Microbioloa, University 
of Zurich, Zurich, Switzerland 
The wall teichoic acids (WTA) in Staphylococcus aureus are lin- 
ear chains of 30 to 40 ribitol phosphate units linked to the 
peptidoglycan. They are substituted with D-alanine esters and 
N-acetylglucosaminyl residues. The WTA are important and in- 
dispensable for normal growth. They serve as structure for phage 
docking to the cells, and have been postulated to play a role in ad- 
